Notícies
http://www.imim.cat/noticies
Programa de recerca:
Informàtica biomèdicaNew computational tool to improve prediction of the genetic impact on diabetes and obesity
http://www.imim.cat/noticies/view.php?ID=880
<p>The <strong>GLP-1 receptor</strong> is a protein that responds to GLP-1, a naturally occurring hormone that <strong>regulates blood sugar levels and feelings of satiety</strong>. It is therefore the target of some of the most advanced and widely used treatments currently available for type 2 diabetes and obesity, such as Ozempic. For this reason, understanding how the function of this receptor may vary depending on genetic changes affecting it is particularly important.</p>
<p>Individuals can naturally carry <strong>different genetic variants of the GLP-1 receptor</strong>, known as GLP1R variants. The individual risk of developing type 2 diabetes and variability in response to treatment may differ depending on the presence of a particular variant.</p>
07/10/2026